Abstract
In the United States, each year there are over 1.5 million traumatic brain injuries (TBIs), resulting in 50,000 deaths.1 TBI induces temporary or permanent impairment of cognition, physical function, and psychosocial behavior.2 TBI severity ranges widely depending on the nature of the injury. The majority of these injuries are classified as “mild” TBI (mTBI), which are challenging to diagnose and track because quantitative biomarkers for mTBI are lacking. In fact, one of the defining characteristics of mTBI is that it cannot be validated through standard methods of clinical imaging.3 Given the difficulty of rapid detection, mTBI poses a particular challenge to public health because repeated injuries such as concussions have a cumulative effect on brain health.4 5. – 6
All Related Versions
Funding Information
  • New York Medical College
  • National Science Foundation (1541612)
  • National Science Foundation (1641133)

This publication has 80 references indexed in Scilit: